Parenteral Drugs (India) reports standalone net loss of Rs 10.70 crore in the September 2015 quarter

Sales rise 23.66% to Rs 58.69 crore

Net Loss of Parenteral Drugs (India) reported to Rs 10.70 crore in the quarter ended September 2015 as against net loss of Rs 17.30 crore during the previous quarter ended September 2014. Sales rose 23.66% to Rs 58.69 crore in the quarter ended September 2015 as against Rs 47.46 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales58.6947.46 24 OPM %8.715.73 -PBDT-5.44-11.96 55 PBT-10.70-16.38 35 NP-10.70-17.30 38

Powered by Capital Market - Live News